Results 141 to 150 of about 585,882 (283)
, 2014 Aim: To investigate the effects of a magnetic field (MF) on febrile seizure latency, seizure duration, and electroencephalographic (EEG) recordings in a rat febrile convulsion ...
Durmus, Nedim +3 more
core +1 more source
Frontiers in PediatricsSmith-Magenis syndrome (SMS) is a rare neurodevelopmental and multisystem disorder caused mainly by 17p11.2 deletions involving RAI1. Because the characteristic behavioral and sleep phenotype may not yet be apparent, diagnosis in infancy can be ...
Yun Cheng +3 more
doaj +1 more source
The Correlation between Hemoglobin Level, Age, and Family History of Febrile Seizure with The Incidence of Febrile Seizure in Children [PDF]
Febrile seizure is a seizure that occur when the body temperature increases and is caused by an extracranial process. There are several risk factors of febrile seizure, including hemoglobin level,-age,-and family history of febrile seizure.
Kartika Setyarini, Tri +2 more
core
Precision immunomodulation for pediatric hemophagocytic lymphohistiocytosis in intensive care
Pediatric Investigation, EarlyView.This review presents a bedside framework for recognizing pediatric hemophagocytic lymphohistiocytosis and cytokine storm, stabilizing organ dysfunction, identifying the underlying phenotype, selecting targeted immunomodulation, considering extracorporeal adjuncts, and reassessing response within 24–72 h. ABSTRACT Hemophagocytic lymphohistiocytosis (HLH)
Weerapong Lilitwat, Prakreeti Bhandari
wiley +1 more source
Development and Behavior Following First Febrile Seizure
, 2013 Investigators at New York Presbyterian Hospital determined the effect of a first febrile seizure (FS) on development, using measures of cognition, motor ability, and adaptive ...
J Gordon Millichap
core +1 more source
Pediatric Investigation, EarlyView.Bortezomib‐based chemotherapy achieved an 88.9% remission rate in Chinese pediatric patients with relapsed/refractory B‐cell acute lymphoblastic leukemia, enabling 62.5% of responders to bridge to transplantation, while T‐cell acute lymphoblastic leukemia showed no response.
Xingyu Zhao +5 more
wiley +1 more source
British Journal of Haematology, EarlyView.BrECADD can be delivered over 3 days instead of four, reducing intravenous treatment days by 25% without compromising dose intensity. Among 30 patients with advanced‐stage Hodgkin lymphoma, no unexpected toxicity was observed; there were no early discontinuations, and 1‐year progression‐free and overall survival were both 100%.
Christian Peter Jaworek +16 more
wiley +1 more source
British Journal of Haematology, EarlyView.Summary Anti‐cluster of differentiation 38 (Anti‐CD38) monoclonal antibodies such as daratumumab are widely used in multiple myeloma (MM), yet the timing and magnitude of infectious risk remain incompletely defined. We performed an individual patient‐level meta‐analysis of six randomized trials (N = 2989) comparing daratumumab‐ versus non‐daratumumab ...
Alissa Visram +7 more
wiley +1 more source
Cancer Science, EarlyView.ABSTRACT Quizartinib is a FMS‐like tyrosine kinase 3 (FLT3) inhibitor indicated for FLT3 internal tandem duplication (FLT3‐ITD)–positive acute myeloid leukemia (AML). We aimed to evaluate quizartinib resistance mechanisms, in addition to efficacy and safety outcomes, in patients with relapsed or refractory FLT3‐ITD–positive AML.
Yuichiro Semba +21 more
wiley +1 more source
Deep Phenotyping in ReNU Syndrome Identifies a Recognizable Age‐Dependent Clinical Trajectory
Clinical Genetics, EarlyView.Longitudinal evaluation of 11 individuals with ReNU syndrome revealed an age‐dependent multisystem trajectory. This longitudinal description may help clinicians anticipate changing needs in feeding, growth, neurological, visual, communication, behavioral, and orthopedic care. ABSTRACT Pathogenic variants in the noncoding gene RNU4‐2 cause ReNU syndrome,
Nadja Pekkola Pacheco +14 more
wiley +1 more source